Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (23)
COVID-19 (6)
Type
(
1 selected
)
Type
Guidance (1856)
NICE advice (323)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (27)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (757)
Apply filters
Showing 591 to 600 of 1856
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Ertugliflozin as monotherapy or with metformin for treating type 2 diabetes
TA572
27 March 2019
27 March 2019
Ertugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetes
TA583
5 June 2019
5 June 2019
Erythropoiesis‑stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy
TA323
26 November 2014
26 November 2014
Esketamine for treating major depressive disorder in adults at imminent risk of suicide (terminated appraisal)
TA899
6 June 2023
6 June 2023
Esketamine nasal spray for treatment-resistant depression
TA854
14 December 2022
14 December 2022
Etanercept and efalizumab for the treatment of adults with psoriasis
TA103
26 July 2006
26 July 2006
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis
TA199
25 August 2010
25 August 2010
Etelcalcetide for treating secondary hyperparathyroidism
TA448
28 June 2017
28 June 2017
Etrasimod for treating moderately to severely active ulcerative colitis in people aged 16 and over
TA956
11 March 2024
11 March 2024
Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease
TA449
28 June 2017
28 June 2017
Previous page
1
…
58
59
Current page
60
61
62
…
186
Page
60
of
186
Next page
Results per page
10
25
50
All
Back to top